Medicare Enrolled
Dr. Casey Jeffreys, M.D.
Neurology · Raleigh, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jeffreys from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jeffreys?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jeffreys
Dr. Casey Jeffreys is a neurology specialist in Raleigh, NC, with 12 years of NPI registration. Based on federal Medicare data, Dr. Jeffreys performed 24,891 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Jeffreys received a total of $70,215 from 58 pharmaceutical and/or device companies across 730 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jeffreys is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 4% volume in NC
$70,215 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗24,891
Medicare services
Top 4% in NC for neurology
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Ocrelizumab infusion (Ocrevus) for MS | 9,300 | $30 | $110 |
| Injection, natalizumab, 1 mg | 8,700 | $19 | $35 |
| MRI contrast dye injection (gadobutrol) | 4,200 | $0 | $2 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,970 | $38 | $90 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
149 | $78 | $220 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
122 | $4 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
83 | $85 | $300 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
58 | $47 | $228 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $119 | $380 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
51 | $81 | $510 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
44 | $56 | $266 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
40 | $150 | $2,235 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
36 | $16 | $166 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
33 | $11 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
21 | $18 | $166 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $60 | $150 |
| MRI of upper spine with contrast An MRI scan of the upper spinal canal using a contrast dye to enhance the images. The contrast helps provide a clearer view of the spinal structures. |
14 | $76 | $1,746 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
37.9% high complexity
60.7% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$70,215
Total received (2018-2024)
Avg $10,031/year across 7 years
Top 8% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
730
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$12,494
2023
$3,082
2022
$13,900
2021
$5,621
2020
$20,401
2019
$13,294
2018
$1,424
Payments by company (2024)
Genentech USA, Inc.
$3,621
EMD Serono, Inc.
$3,165
TG Therapeutics, Inc.
$1,269
Alexion Pharmaceuticals, Inc.
$579
Novartis Pharmaceuticals Corporation
$528
UCB, Inc.
$306
Celgene Corporation
$306
Biogen, Inc.
$262
Mallinckrodt Hospital Products Inc.
$259
ABBVIE INC.
$233
Lilly USA, LLC
$228
PFIZER INC.
$218
ARGENX US, INC.
$206
Amgen Inc.
$186
BANNER LIFE SCIENCES, LLC
$157
CSL Behring
$157
ANI Pharmaceuticals, Inc.
$131
Genentech, Inc.
$120
Ipsen Biopharmaceuticals, Inc
$94
Neurocrine Biosciences, Inc.
$90
Grifols USA, LLC
$79
Vanda Pharmaceuticals Inc.
$70
Merz Pharmaceuticals, LLC
$54
Lundbeck LLC
$29
Teva Pharmaceuticals USA, Inc.
$28
Acorda Therapeutics, Inc
$25
Otsuka America Pharmaceutical, Inc.
$21
Boston Scientific Corporation
$21
Axsome Therapeutics, Inc.
$20
Siemens Medical Solutions USA, Inc.
$19
Neurelis, Inc.
$14
Top 3 companies account for 64.5% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$19,504
Biogen, Inc.
$16,356
Genentech USA, Inc.
$13,518
Novartis Pharmaceuticals Corporation
$6,294
GENZYME CORPORATION
$5,448
TG Therapeutics, Inc.
$1,269
Alexion Pharmaceuticals, Inc.
$1,046
Celgene Corporation
$700
Mallinckrodt Hospital Products Inc.
$572
ABBVIE INC.
$482
Amgen Inc.
$431
UCB, Inc.
$405
Lilly USA, LLC
$401
PFIZER INC.
$372
ARGENX US, INC.
$330
TG THERAPEUTICS, INC.
$270
CSL Behring
$265
BANNER LIFE SCIENCES, LLC
$227
ANI Pharmaceuticals, Inc.
$209
Eisai Inc.
$139
Ipsen Biopharmaceuticals, Inc
$134
Acorda Therapeutics, Inc
$133
Grifols USA, LLC
$132
Axsome Therapeutics, Inc.
$132
Genentech, Inc.
$120
Janssen Pharmaceuticals, Inc
$102
Neurocrine Biosciences, Inc.
$90
SANOFI-AVENTIS U.S. LLC
$88
Otsuka America Pharmaceutical, Inc.
$79
Vanda Pharmaceuticals Inc.
$70
Amneal Pharmaceuticals LLC
$64
Avanir Pharmaceuticals, Inc.
$60
Lundbeck LLC
$59
Merz Pharmaceuticals, LLC
$54
ARBOR PHARMACEUTICALS, INC.
$51
AstraZeneca Pharmaceuticals LP
$47
Avion Pharmaceuticals
$47
Teva Pharmaceuticals USA, Inc.
$42
Biohaven Pharmaceutical Holding Company Ltd.
$42
Banner Life Sciences, LLC
$41
Horizon Therapeutics plc
$38
Neurelis, Inc.
$33
Upsher-Smith Laboratories LLC
$31
SK Life Science, Inc.
$29
Allergan, Inc.
$29
GE HealthCare
$25
Exeltis, USA Inc.
$23
Mitsubishi Tanabe Pharma America, Inc.
$22
Boston Scientific Corporation
$21
Siemens Medical Solutions USA, Inc.
$19
Bausch Health US, LLC
$19
Vertical Pharmaceuticals, LLC
$18
Mallinckrodt Enterprises LLC
$17
E.R. Squibb & Sons, L.L.C.
$16
IDORSIA PHARMACEUTICALS US INC
$16
Collegium Pharmaceutical, Inc.
$15
Biohaven Pharmaceuticals, Inc.
$14
ACADIA Pharmaceuticals Inc
$13
Top 3 companies account for 70.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · AUBAGIO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Biograph Vision 600 (8 Ring/64 CT) · Briviact · COMIRNATY · DIVIGEL · Dhivy · Dysport · ELYXYB - celecoxib · EMGALITY · EVUSHELD · Enspryng · FABRAZYME · Fycompa · Gamunex-C · Hizentra · Horizant · INGREZZA · KESIMPTA · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · Ocrevus Zunovo · Ozanimod · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · QUVIVIQ · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · Soliris · Sunosi · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WaveWriter Alpha Prime 16 · Xeomin · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
115
County median income
$101,763
Nearest hospital to ZIP centroid (approximate)
REX HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Jeffreys is a mixed practice specialist, with above-average Medicare volume (top 4% in NC).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Jeffreys experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Jeffreys performed 9,300 ocrelizumab infusion (ocrevus) for ms services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jeffreys receive payments from pharmaceutical companies?
Yes. Dr. Jeffreys received a total of $70,215 from 58 companies across 730 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jeffreys's costs compare to other neurologists in Raleigh?
Dr. Jeffreys's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jeffreys) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Raleigh
Browse neurologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology